GB2083817A - Process for the preparation of 2-methylene-quinoxaline-1,4-dioxide derivatives - Google Patents
Process for the preparation of 2-methylene-quinoxaline-1,4-dioxide derivatives Download PDFInfo
- Publication number
- GB2083817A GB2083817A GB8127507A GB8127507A GB2083817A GB 2083817 A GB2083817 A GB 2083817A GB 8127507 A GB8127507 A GB 8127507A GB 8127507 A GB8127507 A GB 8127507A GB 2083817 A GB2083817 A GB 2083817A
- Authority
- GB
- United Kingdom
- Prior art keywords
- group
- general formula
- formula
- alkyl
- hydroxyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
2-Methylene-1,4-dioxide derivatives of the general formula (I> <IMAGE> wherein A represents a hydroxyl or an amino group, or a group of the general formula -NH-COOR1, wherein R1 denotes a C1-4 alkyl group; or a group of the general formula -NH-CX-NH2, wherein X stands for oxygen or sulfur; or a group of the formula -NH-C(=NH)-NH2; or a group of the general formula -NH-R2, wherein R2 represents C1-6 alkyl, phenyl, benzyl, hydroxyl or hydroxy-(C2-4alkyl); or a group of the general formula -NH-CO-R3, wherein R3 stands for a C1-20alkyl group, a phenyl group optionally substituted by one, two or three identical or different substituent(s) selected from the group consisting of hydroxyl, amino, nitro, C1-4alkyl, C1-4 alkoxy or halogen; a piperidyl, a pyridyl, a furyl, a nitrofuryl, a pyrazinyl, a pyrimidyl, a naphthyl, a hydroxynaphthyl, a phenylalkyl, an 1,2,4-triazinyl, an alpha , alpha -diphenyl- alpha - hydroxymethyl, a cyanomethyl, a halomethyl or a hydroxymethyl group, are prepared by dehydrating new compounds of the general formula (II> <IMAGE> wherein A has the same meanings as above. The compounds of the general formula (I) possessing bactericidal and weight-gain increasing properties can be obtained in a high purity with an excellent yield by the process according to the invention. A process for the preparation of the new compounds of formula (II) is also disclosed.
Description
SPECIFICATION
Process for the preparation of 2-methylene-quinoxaline- 1 ,4-dioxide derivatives
This invention relates to a new process for the preparation of 2-methylene-quinoxaline-1 4- dioxide derivatives known to posses bactericidal and weight-gain increasing effects.The compounds prepared according to the invention are encompassed by the general formula (I)
wherein
A represents a hydroxyl or an amino group, or a group of the general formula -NH-COOR" wherein R, denotes a C, 4 alkyl group; or a group of the general formula -NH-CX-NH2, wherein X stands for oxygen or sulfur; or a group of the formula -NH-C(= NH)-NH2; or a group of the general formula -NH-R2, wherein R2 represents C1 6 alkyl, phenyl, benzyl, hydroxyl or hydroxy-(C2 4alkyl); or a group of the general formula -NH-CO-R3, wherein R3 stands for a C, 20 alkyl group, a phenyl group optionally substituted by one, two or three identical or different substituent(s) selected from the group consisting of hydroxyl, amino, nitro, C14 alkyl, C14 alkoxy or halogen; a piperidyl, a pyridyl, a furyl, a nitrofuryl, a pyrazinyl, a pyrimidyl, a naphthyl, a hydroxynaphthyl, a phenylalkyl, an 1,2,4-triazinyl, an a,a-diphenyl-a-hydrnxymethyl, a cyanomethyl, a halomethyl or a hydroxymethyl group.
The term "alkyl group" used in the specification and claims covers straight-chained or branched saturated aliphatic hydrocarbyl groups, such as methyl, ethyl, n-propyl, isopropyl, nbutyl, sec.-butyl, and tert.-butyl. The term "alkoxy group" refers to groups derived from the alkyl groups mentioned above, such as methoxy, ethoxy, n-propoxy, isopropoxy, and n-butoxy.
Preferred representatives of the "hydroxy-(C24 alkyl)" groups are the hydroxyethyl, hydroxypropyl, hydroxyisopropyl and the hydroxybutyl groups. The term "halogen" may stand for all the four halogen atoms, such as fluorine, chlorine, bromine and iodine. The term "halomethyl group" refers to methyl groups substituted by a halogen atom, such as fluoromethyl, chloromethyl, bromomethyl and iodomethyl.
It is known from the US patent specifications Nos. 3,371,090 and 3,493,572 that the compounds of the general formula (I) can be prepared by reacting 2-formyl-quinoxaline-1,4- dioxide or the dialkyl-acetal thereof with a reactant containing a primary amino group. The reaction is unfavourable because of the moderate yield(about 80%)and the relatively long reaction time, which, in certain cases, can be as long as 24 hours. Besides, the main reaction is accompanied by different side-reactions, and the desired compound is contaminated with the side-products thus-formed. The purification of the end-product requires complicated operations and can be carried out only at the expense of high losses of substance.
According to a further known method the compounds of the general formula (I) are produced by reacting 2-formyl-quinoxaline-1 ,4-dioxide or the corresponding dialkyl-acetal with a Schiff base(Hungarian patent specification No. 171,738).
Now it has been found that the compounds of the general formula (I) can be prepared economically in an excellent purity by dehydrating a 2-hydroxymethyl-quinoxaline-1 ,4-dioxide derivative of the general formula (II)
wherein
A has the same meanings as above.
The dehydration can be carried out in two different ways: either thermally, that is by heating the compound of the general formula (II), or by using a dehydrating agent.
When dehydrating under thermal conditions a suspension of the compound of the general formula (11) is preferably heated in a suitably inert solvent until no more water is split off. As suitably inert solvent, water, aliphatic alcohols, such as isopropanol or butanol, or aromatic hydrocarbons, such as toluene or xylene are preferably used. The reaction is preferably carried out at the boiling point of the solvent, generally at 40 C to 150 C. When using an organic solvent immiscible with water the thermal dehydration can be carried out by continually removing the water obtained from the system, e.g. in form of an azeotrope. In this way the reaction may also be monitored.
When dehydrating according to the other method, dehydrating agents generally used for such purpose (e.g. polyphosphoric acid, sulfuric acid, and calcium chloride,) are used.
The 2-hydroxymethyl-quinoxaline-1 ,4-dioxide derivatives of the general formula (II) used as starting substances are new compounds which can be prepared by reacting a 2-methylene quinoxaline-1 ,4-dioxide derivative of the general formula (Ill)
wherein
Q represents an oxygen atom or two alkoxy groups containing 1-4 carbon atoms each, with a carboxylic hydrazide of the general formula (IV)
A-N H2 (IV) wherein A has the same meanings as above.
As the dehydration of the compounds of the general formula (II) is carried out quickly, the side-product formation is eliminated and the compounds of the general formula (I) can be obtained economically, almost quantitatively.
Further details of the invention are illustrated by the following non-limiting Examples:
Preparation of the starting substances of the general formula (11):
0.1 mole of 2-formyl-quinoxaline-1,4-dioxide dissolved in water or dimethylformamide is reacted with 0.1 mole of a compound of the general formula (IV) in the presence of 2 drops of concentrated hydrochloric acid or piperidine. The separated product is filtered off, washed with water and dried.
Example 1
Preparation of 2-(methoxycarbonyl-hydrazono-methylene)-quinoxaline-1,4-dioxide
28.0 g (0.1 mole) of 2-(α-)methoxycarbonyl-hydrazino-(-α-hydroxymethyl)-quinoxaline-1,4-diox- ide are admixed with 150 ml of water and the mixture is boiled for an hour under stirring. Then it is cooled, the separated product is filtered off and washed with water. 25.4 g (98%) of desired compound are obtained.
M.p.: 257-258 C.
Example 2
Preparation of 2-(3', 4', 5'- trimethoxybenzoyl-hydrazonomethylene)-quinoxaline-1,4-dioxide
41.6 g (0.1 mole) of 2-(α-) 3,4,5-trimethoxybenzoyl-hydrazino(-α-quinoxaline- 1,4-dioxide are dehydrated in 250 ml of isopropanol, in the presence of 2 drops of sulfuric acid at 50 C to 60 C, under stirring. After cooling the reaction mixture the separated product is filtered off and washed. 39.0 g(98%) of desired compound are obtained. M.p.: 255-256 C.
Example 3
Preparation of 2-(cyanoacetyl-hydrazono-methylene)-quinoxaline-1,4-dioxide
27.2 g(0.1 mole)of 2-(α-)cyanoacetyl-hydrazone(-α-hydroxymethyl)-quinoxaline-1,4-dioxide are suspended in 200 ml of toluene, and the reaction mixture is kept at 1 20 C for an hour. Then it is cooled, and the separated product is filtered off. 26.0 g(97%)of desired compound are obtained. M.p.: 244-245"C.
Example 4
Preparation of 2-(3l, 4,, 5'-trimethoxybenzoyl-hydrazonomethylene)-quinoxaline- 1,4-dioxide 4.1 6 g(0.01 mole) of 2-(α-)3', 4', 5'- trimethoxybenzoylhydrazino(-α-hydroxymethyl)-quinoxal- ine-1,4-dioxide mixed with 40 g of polyphosphoric acid are allowed to react at 25"C for 3 hours, then the reaction mixture is poured into a 10% cold sodium hydroxide solution. The separated precipitate is filtered off and washed with water until neutral. 38.6 g(97%) of desired compound are obtained. M.p.: 256-256.5"C.
The compounds listed in the following Table are prepared by the methods of the previous
Examples:
Method Example (No. of the Temperature M.P. (No.) A Medium Example) ( C) ( C) Yield 5 -NH-CO-NH2 water 1 90-95 288-89 91 6 -OH isopropanol 2 50 248-49 95 7 -NH-C(NH)-NH2 water 1 80-90 286-87 93 8 -NH-C6H5 water 1 90-95 247-48 89 9 -NH-laurinoyl water 1 80-90 233-34 95 10 -NH-CO-C6H5 water 1 90-95 256-57 98 11 -NH-CO-naphthyl-1 isopropanol 2 60 247-48 97 12 -NH-CO-C6H5-p-OH water 1 50-55 307-08 98 13 -NH-CO-C6H5-p-NH2 water 1 80-85 291-92 95 14 -NH-CO-piridyl-3 methanol 2 50 270-71 94 15 -NH-CO-piridyl-4 butanol 2 50 268-69 96 16 -NH-CO-C6H5-p-Cl water 1 50 273-74 97 17 -NH-CO-furyl-2 xylene 3 120 261-62 95 18 -NH-CO-C6H5-2-NH2 water 1 60 289-90 94 19 -NH-CO-furyl-5-NO2 methanol 2 50 265 95 20 -NH-CO-C6H5-2-OH water 1 50 280 94 21 -NH-caprinoyl water 1 90-95 237-38 97 22 -NH-CO-C6H5-p-NO2 water 1 90-95 275-76 95 23 -NH-CO-(CH2)2-C6H5 isopropanol 2 50 241 98 24 -NH-stearinoyl butanol 2 50 233-34 90 25 -NH-CO-C6H5-p-OCH3 xylene 3 110 260 91 26 -NH-CO-piperidyl-4 isopropanol 2 60 185-86 90 27 -NH-CO-naphthyl(2)-2-OH water 1 90-95 261 98 28 -NH-heptanoyl methanol 2 55-60 241-42 97 29 -NH-CH3 water 1 80-90 183 89 30 -NH-C4H9 water 1 90-95 230-31 92 31 -NH-benziloyl toluene 3 110 252-53 96 32 -NH-(CH2)2-OH xylene 3 130 258-59 89 33 -NH-CS-NH2 water 1 90-95 292-93 88 34 -NH-CO-C(C6H5)2 water 1 50 267 97 OH
Claims (10)
1. A process for the preparation of 2-methylene-quinoxaline-1 4-dioxide derivatives of the general formula (I)
wherein A represents a hydroxyl or an amino group, or a group of the general formula -NH-COOR1, wherein R, denotes a C14 alkyl group; or a group of the general formula -NH-CX-NH2, wherein X stands for oxygen or sulfur; or a group of the formula -NH-C(= NH)
NH2; or a group of the general formula -NH-R2, wherein S2 represents C12 alkyl, phenyl, benzyl, hydroxyl or hydroxy-(C2 4 alkyl); or a group of the general formula -NH-CO-R3, wherein
R3 stands for a C, 20 alkyl group, a phenyl group optionally substituted by one, two or three identical or different substituent(s) selected from the group consisting of hydroxyl, amino, nitro, C14 alkyl, C14 alkoxy or halogen; a piperidyl, a pyridyl, a furyl, a nitrofuryl, a pyrazinyl, a pyrimidyl, a naphthyl, a hydroxynaphthyl, a phenylalkyl, an 1,2,4-triazinyl, an a,a-diphenyka- hydroxymethyl, a cyanomethyl, a halomethyl or a hydroxymethyl group, which comprises dehydrating a compound of the general formula (II)
wherein A has the same meanings as above.
2. A process as claimed in claim 1, wherein the dehydration is carried out in an inert solvent, at the boiling point thereof.
3. A process as claimed in claim 2, wherein the inert solvent is water, an aliphatic alcohol or an aromatic hydrocarbon.
4. A process as claimed in claim 1, wherein the dehydration is carried out using a dehydrating agent.
5. A process as claimed in claim 4, wherein the dehydrating agent is polyphosphoric acid, sulfuric acid or calcium chloride.
6. A process as claimed in claim 1 substantially as hereinbefore described.
7. A process as claimed in claim 1 substantially as hereinbefore described with reference to the Examples.
8. Compounds of formula (II) as defined in claim 1.
9. A process for the preparation of a compound of formula (II) as defined in claim 1 which comprises reacting a compound of formula (III)
wherein Q represents an oxygen atom or two alkoxy groups containing from 1 to 4 carbon atoms, with a carboxylic hydrazide of formula
A-NH2 wherein A is as defined in claim 1.
10. A process as claimed in claim 9 substantially as hereinbefore described.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU224080 | 1980-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB2083817A true GB2083817A (en) | 1982-03-31 |
Family
ID=10958457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8127507A Withdrawn GB2083817A (en) | 1980-09-12 | 1981-09-11 | Process for the preparation of 2-methylene-quinoxaline-1,4-dioxide derivatives |
Country Status (14)
Country | Link |
---|---|
AR (1) | AR226749A1 (en) |
BE (1) | BE890300A (en) |
CA (1) | CA1154770A (en) |
DE (1) | DE3136092A1 (en) |
DK (1) | DK405181A (en) |
ES (1) | ES505442A0 (en) |
FI (1) | FI812835L (en) |
FR (1) | FR2490226A1 (en) |
GB (1) | GB2083817A (en) |
IL (1) | IL63803A0 (en) |
IT (1) | IT1139962B (en) |
PT (1) | PT73655B (en) |
SE (1) | SE8105427L (en) |
YU (1) | YU218781A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102617493A (en) * | 2012-02-22 | 2012-08-01 | 中国农业大学 | Mequindox artificial antigens and antibodies prepared by same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1469485A (en) * | 1964-09-16 | 1967-02-17 | Pfizer & Co C | Process for the preparation of a new series of schiff bases |
US3493572A (en) * | 1968-07-05 | 1970-02-03 | Pfizer & Co C | Process for producing quinoxaline-di-n-oxides |
US3926992A (en) * | 1972-11-03 | 1975-12-16 | Pfizer | Aldol products of 2-quinoxalinecarboxaldehy-1,4-dioxides |
US4221791A (en) * | 1979-05-21 | 1980-09-09 | International Minerals & Chemical Corp. | Substituted quinoxaline dioxides |
-
1981
- 1981-09-10 BE BE1/10310A patent/BE890300A/en not_active IP Right Cessation
- 1981-09-11 FI FI812835A patent/FI812835L/en not_active Application Discontinuation
- 1981-09-11 SE SE8105427A patent/SE8105427L/en not_active Application Discontinuation
- 1981-09-11 IT IT23898/81A patent/IT1139962B/en active
- 1981-09-11 CA CA000385733A patent/CA1154770A/en not_active Expired
- 1981-09-11 PT PT73655A patent/PT73655B/en unknown
- 1981-09-11 IL IL63803A patent/IL63803A0/en unknown
- 1981-09-11 FR FR8117209A patent/FR2490226A1/en active Pending
- 1981-09-11 GB GB8127507A patent/GB2083817A/en not_active Withdrawn
- 1981-09-11 DK DK405181A patent/DK405181A/en not_active Application Discontinuation
- 1981-09-11 AR AR286743A patent/AR226749A1/en active
- 1981-09-11 YU YU02187/81A patent/YU218781A/en unknown
- 1981-09-11 DE DE19813136092 patent/DE3136092A1/en not_active Withdrawn
- 1981-09-12 ES ES505442A patent/ES505442A0/en active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102617493A (en) * | 2012-02-22 | 2012-08-01 | 中国农业大学 | Mequindox artificial antigens and antibodies prepared by same |
CN102617493B (en) * | 2012-02-22 | 2014-06-04 | 中国农业大学 | Mequindox artificial antigens and antibodies prepared by same |
Also Published As
Publication number | Publication date |
---|---|
PT73655B (en) | 1982-11-22 |
IT8123898A0 (en) | 1981-09-11 |
AR226749A1 (en) | 1982-08-13 |
IL63803A0 (en) | 1981-12-31 |
DE3136092A1 (en) | 1982-05-27 |
BE890300A (en) | 1982-03-10 |
YU218781A (en) | 1983-04-30 |
ES8206492A1 (en) | 1982-08-16 |
FI812835L (en) | 1982-03-13 |
DK405181A (en) | 1982-03-13 |
CA1154770A (en) | 1983-10-04 |
FR2490226A1 (en) | 1982-03-19 |
SE8105427L (en) | 1982-03-13 |
IT1139962B (en) | 1986-09-24 |
PT73655A (en) | 1981-10-01 |
ES505442A0 (en) | 1982-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900003512B1 (en) | Antibacterial carboxylic acid derivatives | |
US5182389A (en) | Process for the preparation of 2-(2',4'-dihydroxyphenyl)-4,6-diaryl-s-triazines | |
US4981966A (en) | Process for the preparation of quinoline carboxylic acids | |
KR970005911B1 (en) | Process for preparing quinoline carboxylic acid derivatives | |
SE8700597L (en) | INTERMEDIATES FOR THE PRODUCTION OF EBURNAMON DERIVATIVES AND PROCEDURE FOR THE PRODUCTION OF THESE INTERMEDIATES | |
EP0309537B1 (en) | Process for the preparation of quinoline carboxylic acids | |
US4994599A (en) | Intermediates for producing quinolone-3-carboxylic acids | |
HU182636B (en) | Process for producing pyrazolo-imidazol derivatives | |
US4675432A (en) | Method for the preparation of anilinofumarate | |
KR100253047B1 (en) | Verfahren zur herstellung von 8-chlorochinolomderivaten | |
EP0052333B1 (en) | 4-fluoro-5-oxypyrazole derivate and preparation thereof | |
GB2083817A (en) | Process for the preparation of 2-methylene-quinoxaline-1,4-dioxide derivatives | |
US5155223A (en) | Preparation of quinolinecarboxylic acids | |
CA2504796A1 (en) | Polymorphs of pantoprazole sodium salt and process for the preparation thereof | |
SU545262A3 (en) | The method of obtaining derivatives of 4-oxo-4-pyrano- (3,2-c) quinoline-2-carboxylic acids or their salts | |
US4894457A (en) | 7-bromo-beta-carboline compound and method for producing same | |
US4292431A (en) | Process for the production of hydroxymethylimidazoles | |
EP0248876B1 (en) | Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives | |
CS202069B2 (en) | Method of preparing 2-/4-substituted piperazine-1-yl/-4-amino-6,7-dimethoxyquinazolines | |
KR100235375B1 (en) | Method for preparing optical isomers of a 2-amino naphthyridine derivative | |
EP0393109B1 (en) | Novel 2,3-thiomorpholinedione-2-oxime derivatives, pharmaceutical compositions containing them and process for preparing same | |
AU622256B2 (en) | Process for the preparation of quinoline carboxylic acid derivatives | |
IE852609L (en) | DIOXINO (4,5-c) PYRIDINE DERIVATIVES | |
US5739331A (en) | Process for converting a xanthine ring or xanthine ring derivatives into dialkylaminoxanthine derivatives | |
US4847405A (en) | Method for the preparation of anilinofumarate [quinoline-2,3- dicarboxylic] |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |